This strategic alliance brings together the longstanding oncology diagnostic experience of Myriad Genetics and the clinical and translational research expertise of MD Anderson to create a portfolio of ...

The University of Texas MD Anderson Cancer Center and Myriad Genetics (MYGN) announced a five-year strategic alliance to accelerate the ...